Numerate's Series B Round

Numerate raised a round of funding on March 16, 2009.

Numerate is a privately held biotechnology company that applies novel machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discovery. Numerate's drug design…

Articles about Numerate's Series B Round: